diphenoxylate hydrochloride and atropine sulfate tablets
SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent
18,003 recalls, newest first
SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent
Failed Impurities/Degradation Specifications.
Failed Impurities/Degradation Specifications.
Lack Of Assurance Of Sterility.
Lack Of Assurance Of Sterility.
Lack Of Assurance Of Sterility.
Lack Of Assurance Of Sterility.
Lack Of Assurance Of Sterility.
Lack Of Assurance Of Sterility.
Lack Of Assurance Of Sterility.
Lack Of Assurance Of Sterility.
Lack Of Assurance Of Sterility.
Lack Of Assurance Of Sterility.
Failed Dissolution Specifications: Low out of specification results for dissolution.
Superpotent drug: out of specification result for potency
Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.
Presence of foreign substance (screw)
Labeling: Incorrect or Missing Package Insert.
Lack of Assurance of Sterility.
Lack of Assurance of Sterility.
Lack of Assurance of Sterility.
Lack of Assurance of Sterility.
Lack of Assurance of Sterility.
Lack of Assurance of Sterility.
Lack of Assurance of Sterility.